What is the equivalent dose of Vyvanse (lisdexamfetamine) for a patient taking Adderall (amphetamine and dextroamphetamine) 15mg three times a day (TID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall 15mg TID to Vyvanse Conversion

For a patient taking Adderall 15mg three times daily (total daily dose 45mg), convert to Vyvanse 70mg once daily in the morning. 1

Conversion Calculation

  • Total daily Adderall dose: 15mg × 3 = 45mg per day
  • Conversion ratio: Apply approximately 2.5:1 (Vyvanse:Adderall) when switching between these amphetamine formulations 1
  • Calculated Vyvanse equivalent: 45mg × 2.5 = 112.5mg
  • Practical dose: Since the maximum FDA-approved dose of Vyvanse is 70mg daily, start at 70mg once daily in the morning 1, 2

Rationale for Maximum Dose

  • Vyvanse is dosed once daily with a maximum of 70mg, and can be adjusted in 10mg increments at weekly intervals if needed 1, 3
  • The 70mg dose represents the ceiling for this medication regardless of prior stimulant exposure 2, 4
  • Lisdexamfetamine (Vyvanse) is a prodrug that is enzymatically hydrolyzed primarily in red blood cells to active d-amphetamine, providing extended duration of effect up to 14 hours in adults 2, 3

Switching Protocol

  • Discontinue Adderall immediately without tapering when switching to Vyvanse, as no washout period is required between amphetamine formulations 5
  • Initiate Vyvanse 70mg the following morning as a single daily dose 1, 3
  • Timing: Administer in the morning to minimize sleep disturbances 6

Monitoring After Conversion

  • Vital signs: Check blood pressure and pulse at baseline and with each follow-up, as stimulants can increase both parameters 6, 5
  • Efficacy assessment: Use standardized ADHD rating scales to evaluate symptom control at weekly intervals initially 6
  • Follow-up schedule: Monthly appointments until symptoms are stabilized, then at least every 3 months 6
  • Duration of effect: Vyvanse provides efficacy for 14 hours post-dose in adults, which may better cover late-day symptoms compared to multiple daily Adderall doses 2, 3

Common Pitfalls to Avoid

  • Do not attempt to exceed 70mg Vyvanse even though the mathematical conversion suggests a higher dose—70mg is the regulatory maximum 1, 2
  • Do not split the Vyvanse dose into multiple daily administrations; it is designed as once-daily therapy 3, 4
  • Do not overlook cardiovascular monitoring, particularly in patients with pre-existing hypertension or cardiac conditions 6
  • Avoid evening dosing as the extended duration of Vyvanse (up to 14 hours) will cause insomnia 2, 3

Expected Adverse Effects

  • Most common side effects include decreased appetite, insomnia, headache, irritability, and nausea—consistent with amphetamine products generally 3, 4
  • These effects are typically mild to moderate in intensity and transient 4
  • The tolerability profile of Vyvanse is consistent with other long-acting stimulants 2, 3

If Inadequate Response at 70mg

  • Reassess diagnosis and evaluate for comorbid conditions affecting treatment response (sleep disorders, anxiety, depression) 6
  • Consider alternative stimulant formulations or adding a non-stimulant medication like atomoxetine 6
  • Evaluate adherence and timing of administration to ensure optimal therapeutic effect 6

References

Guideline

Equivalent Dose of Vyvanse for 20mg Adderall

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Switching from Adderall to Atomoxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dose Considerations and Monitoring for Adults with ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.